Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4459027
Max Phase: Preclinical
Molecular Formula: C19H16N2O3
Molecular Weight: 320.35
Molecule Type: Unknown
Associated Items:
ID: ALA4459027
Max Phase: Preclinical
Molecular Formula: C19H16N2O3
Molecular Weight: 320.35
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(O)c1coc2c(=O)n3c(cc12)-c1[nH]c2ccccc2c1CC3
Standard InChI: InChI=1S/C19H16N2O3/c1-10(22)14-9-24-18-13(14)8-16-17-12(6-7-21(16)19(18)23)11-4-2-3-5-15(11)20-17/h2-5,8-10,20,22H,6-7H2,1H3
Standard InChI Key: ROKKVZCZBYYCSY-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 320.35 | Molecular Weight (Monoisotopic): 320.1161 | AlogP: 3.35 | #Rotatable Bonds: 1 |
Polar Surface Area: 71.16 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.58 | CX Basic pKa: | CX LogP: 1.61 | CX LogD: 1.61 |
Aromatic Rings: 4 | Heavy Atoms: 24 | QED Weighted: 0.56 | Np Likeness Score: 0.53 |
1. Kezetas Bankeu JJ, Kenou Kagho DU, Fotsing Fongang YS, Kouipou Toghueo RM, Mba'ning BM, Tchouya Feuya GR, Boyom Fekam F, Tchouankeu JC, Ngouela SA, Sewald N, Lenta BN, Ali MS.. (2019) Constituents from Nauclea latifolia with Anti-Haemophilus influenzae Type b Inhibitory Activities., 82 (9): [PMID:31429278] [10.1021/acs.jnatprod.9b00463] |
Source(1):